Marc Delforge

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff

Charlotte Martin, Isabel Montesinos, Nicolás Dauby et al. · Journal of Hospital Infection · 2020 · 105 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +15

Sustained Viral Suppression and Higher CD4+ T-Cell Count Reduces the Risk of Persistent Cervical High-Risk Human Papillomavirus Infection in HIV-Positive Women

Déborah Konopnicki, Yannick Manigart, Christine Gilles et al. · The Journal of Infectious Diseases · 2013 · 79 citations · Full text

Medicine, Gynecology, Infectious Diseases +17

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

Margalida Rotger, Tracy R. Glass, Thomas Junier et al. · Clinical Infectious Diseases · 2013 · 74 citations · Full text

Life Sciences, Cardiology, Genetics +16

Characteristics of non‐AIDS‐defining malignancies in the HAART era: a clinico‐epidemiological study

Nicolás Dauby, Stéphane De Wit, Marc Delforge et al. · Journal of the International AIDS Society · 2011 · 56 citations · Full text

Public Health, Health Sciences, Oncology +17